These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of the cognitive benefits of intrathecal baclofen pump implantation in people with intractable multiple sclerosis related spasticity. Farrell R; Summers M; Doogan C; Mulhert N; Keenan E; Buchanan K; Lee H; Padilla H; Stevenson VL Mult Scler Relat Disord; 2021 May; 50():102831. PubMed ID: 33618123 [TBL] [Abstract][Full Text] [Related]
4. Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: a case report. Santamato A; Panza F; Ranieri M; Amoruso MT; Amoruso L; Frisardi V; Solfrizzi V; Fiore P J Rehabil Med; 2010 Oct; 42(9):891-4. PubMed ID: 20878052 [TBL] [Abstract][Full Text] [Related]
6. [Management of spasticity in children with cerebral palsy]. Matthews DJ; Balaban B Acta Orthop Traumatol Turc; 2009; 43(2):81-6. PubMed ID: 19448346 [TBL] [Abstract][Full Text] [Related]
7. Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability. Charles PD; Gill CE; Taylor HM; Putman MS; Blair CR; Roberts AG; Ayers GD; Konrad PE Mov Disord; 2010 Mar; 25(4):466-73. PubMed ID: 20131401 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury. Yoon YK; Lee KC; Cho HE; Chae M; Chang JW; Chang WS; Cho SR Medicine (Baltimore); 2017 Aug; 96(34):e7472. PubMed ID: 28834868 [TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of spasticity in children with cerebral palsy. Chung CY; Chen CL; Wong AM J Formos Med Assoc; 2011 Apr; 110(4):215-22. PubMed ID: 21540003 [TBL] [Abstract][Full Text] [Related]
10. Considerations in the treatment of spasticity with intrathecal baclofen. Mullarkey T Am J Health Syst Pharm; 2009 Sep; 66(17 Suppl 5):S14-22. PubMed ID: 19710446 [TBL] [Abstract][Full Text] [Related]
11. Intrathecal baclofen for spasticity management: a comparative analysis of spasticity of spinal vs cortical origin. Saval A; Chiodo AE J Spinal Cord Med; 2010; 33(1):16-21. PubMed ID: 20397440 [TBL] [Abstract][Full Text] [Related]
12. Intrathecal baclofen for severe spasticity secondary to spinal cord injury. Lewis KS; Mueller WM Ann Pharmacother; 1993 Jun; 27(6):767-74. PubMed ID: 8329801 [TBL] [Abstract][Full Text] [Related]
13. Spasticity after stroke. Epidemiology and optimal treatment. O'Brien CF; Seeberger LC; Smith DB Drugs Aging; 1996 Nov; 9(5):332-40. PubMed ID: 8922560 [TBL] [Abstract][Full Text] [Related]
14. A benefit-risk assessment of baclofen in severe spinal spasticity. Dario A; Tomei G Drug Saf; 2004; 27(11):799-818. PubMed ID: 15350152 [TBL] [Abstract][Full Text] [Related]
15. Spasticity: a rehabilitation challenge in the elderly. Barnes MP Gerontology; 2001; 47(6):295-9. PubMed ID: 11721141 [TBL] [Abstract][Full Text] [Related]
16. Intrathecal Baclofen therapy in Germany: Proceedings of the IAB-Interdisciplinary Working Group for Movement Disorders Consensus Meeting. Dressler D; Berweck S; Chatzikalfas A; Ebke M; Frank B; Hesse S; Huber M; Krauss JK; Mücke KH; Nolte A; Oelmann HD; Schönle PW; Schmutzler M; Pickenbrock H; Van der Ven C; Veelken N; Vogel M; Vogt T; Saberi FA J Neural Transm (Vienna); 2015 Nov; 122(11):1573-9. PubMed ID: 26179478 [TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment. Sheean G Drug Saf; 2006; 29(1):31-48. PubMed ID: 16454533 [TBL] [Abstract][Full Text] [Related]
18. The pharmacological management of post-stroke muscle spasticity. Bakheit AM Drugs Aging; 2012 Dec; 29(12):941-7. PubMed ID: 23138834 [TBL] [Abstract][Full Text] [Related]
19. Intrathecal Baclofen Infusion for the Treatment of Movement Disorders. Lake W; Shah H Neurosurg Clin N Am; 2019 Apr; 30(2):203-209. PubMed ID: 30898271 [TBL] [Abstract][Full Text] [Related]